Physician profile

Srinivas Koneru

Cardiovascular Disease · Sterling Heights, MI

NPI 1477599587

$42,030.56

in general payments reported to CMS, 2019-2025

49 companies · $12K in 2025

The $12K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Long Term Medical Supply Or Device Loan$25,500.01
Food and Beverage$7,047.06
Travel and Lodging$1,298.83

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Angiodynamics, INC. $25,563.10 2022-2025 Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac
Medtronic, INC. $2,964.97 2021-2025 Symplicity G3, Onyx Frontier, Abre
Boston Scientific Corporation $2,819.33 2019-2025 Seismiq Lithotrip_pi, General - Vascular Intervention, Ranger
Abbott Laboratories $2,671.37 2022-2025 Perclose Proglide, Diamondback Peripheral, Esprit
Medtronic Vascular, INC. $1,395.02 2019-2020
Janssen Pharmaceuticals, INC $869.07 2019-2024 Xarelto
Novartis Pharmaceuticals Corporation $793.09 2019-2025
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $625.74 2019-2025 Lifevest
Inari Medical, INC. $578.46 2022-2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
E.R. Squibb & Sons, L.L.C. $541.58 2021-2025 Camzyos, Eliquis
Merck Sharp & Dohme LLC $442.87 2021-2025 Verquvo
Amgen INC. $323.57 2019-2025 Repatha, Repatha
Kiniksa Pharmaceuticals, LTD. $264.59 2021-2023 Arcalyst
Kestra Medical Technology Services, INC. $224.80 2023-2025 Assure Wcd
Astellas Pharma US INC $221.95 2019-2021
Show all 49 companies
CompanyGeneral paymentsYearsTop products
Pfizer INC. $183.58 2019-2025
Boehringer Ingelheim Pharmaceuticals, INC. $147.48 2020-2023 Jardiance
Amarin Pharma, INC. $116.09 2019-2022
Sanofi-Aventis U.S. LLC $105.61 2019-2022
Esperion Therapeutics, INC. $90.15 2020-2022
Astrazeneca Pharmaceuticals LP $82.66 2019-2021
Cordis US Corp. $71.66 2021-2023 Mynx Control, Outback Elite
Cardiva Medical, INC. $69.69 2020-2024 Cardiva Vascade 6/7f Vcs
Philips North America LLC $69.08 2019-2024 (5044) Mcot
Vital Connect, INC $64.31 2024 Vitalpatch Rtm
Gilead Sciences, INC. $60.59 2019
Terumo Medical Corporation $58.75 2019
Bayer Healthcare Pharmaceuticals INC. $55.08 2021-2022
Preventice Services, LLC $47.25 2019-2021
Bardy Diagnostics, INC. $45.60 2020-2021
Biotronik INC. $43.80 2021
Cardinal Health 200 LLC $38.48 2019-2021
Abiomed $38.30 2023-2025 Impella
Heartflow, INC. $37.85 2023 Ffrct
Baxter Healthcare $33.15 2023 Hillrom - Carnation Ambulatory Monitor
Teleflex LLC $33.03 2020-2021
Shockwave Medical, INC $30.12 2025
Stryker Corporation $27.42 2025 Flowtriever
Vivaquant INC, Dba Rhythm Express $22.64 2024-2025 Rhythm Express, Rhythm Express
Novo Nordisk INC $21.02 2025 Wegovy
Chiesi USA, INC. $21.01 2022
Regeneron Healthcare Solutions, INC. $19.20 2019
Biohaven Pharmaceutical Holding Company LTD. $16.34 2022
Veryan Medical Incorporated $15.14 2021
Abbvie INC. $14.61 2021
Avinger INC. $14.34 2019
Cardiovascular Systems INC. $13.74 2019
Cashflow Solutions, LLC $12.15 2022
Reflow Medical INC $11.13 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Srinivas Koneru

$42,030.56

in general payments reported 2019-2025

Years
2019-2025
Top company
Angiodynamics, INC.
Context
The $12K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/293455/srinivas-koneru

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.